Related Experiment Video
Updated: Apr 20, 2026
A Reverse Genetic Approach to Test Functional Redundancy During Embryogenesis
Published on: August 11, 2010
GATA2 deficiency
Amy P Hsu1, Lisa J McReynolds, Steven M Holland
1aLaboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases bPediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Insights
GATA2 deficiency, a genetic disorder, causes diverse health issues including infections and blood disorders. Hematopoietic stem cell transplantation offers effective treatment, reversing most symptoms with positive long-term results.
Area of Science:
- Genetics
- Hematology
- Immunology
Background:
- GATA2 deficiency is a germline disorder with a broad range of clinical manifestations.
- Phenotypes include susceptibility to infections, cytopenias, myelodysplasia, leukemias, pulmonary alveolar proteinosis, and lymphedema.
- Clinical presentation varies widely, from early childhood to late adulthood.
Purpose of the Study:
- To review the expanding phenotype associated with GATA2 deficiency.
- To discuss the molecular genetics of GATA2-related diseases.
- To outline recent developments in treatment strategies.
Main Methods:
- Literature review of GATA2 deficiency.
- Analysis of genetic mutations and their impact.
- Evaluation of treatment outcomes, particularly hematopoietic stem cell transplantation.
Main Results:
- GATA2 mutations are found in up to 10% of individuals with congenital neutropenia or aplastic anemia.
- Mutations lead to haploinsufficiency, affecting GATA2 regulation and function.
- Patients with GATA2 mutations face a high risk of myelodysplasia and leukemia.
- Bone marrow transplantation has shown success in treating both hematopoietic and pulmonary alveolar proteinosis aspects of the disease.
Conclusions:
- GATA2 is crucial for hematopoiesis and lymphatic development.
- GATA2 deficiency presents variably but increases susceptibility to infections and hematologic malignancies.
- Hematopoietic stem cell transplantation can reverse most clinical phenotypes, demonstrating good long-term outcomes.
Purpose Of Review:
GATA2 deficiency is a germline disease that causes a wide spectrum of phenotypes including viral and bacterial infections, cytopenias, myelodysplasia, myeloid leukemias, pulmonary alveolar proteinosis and lymphedema. The age of clinical presentation ranges from early childhood to late adulthood, with most occurring in adolescence to early adulthood. We review the expanding GATA2-deficient phenotype, molecular genetics of disease and developments in treatment.
Recent Findings:
GATA2 mutations have been found in up to 10% of those with congenital neutropenia and/or aplastic anemia. Heterozygous mutations appear to cause haploinsufficiency due to either protein dysfunction or uniallelic reduced transcription. Disease-associated mutations in intronic regulatory elements or variations within the 5' leader exons indicate that regulation of GATA2 is critical. Those with GATA2 mutations are at high risk for myelodysplasia, cytogenetic abnormalities, acute myeloid leukemia or chronic myelomonocytic leukemia. Bone marrow transplantation has been successful for both hematopoietic and pulmonary alveolar proteinosis repair.
Summary:
GATA2 is a zinc finger transcription factor essential for embryonic and definitive hematopoiesis as well as lymphatic angiogenesis. GATA2 deficiency is caused by a variety of mutations in the GATA2 gene and can have variable presentation, onset and outcome. Patients are susceptible to mycobacterial, viral and fungal infections and can develop myelodysplasia, acute or chronic leukemias, lymphedema and pulmonary alveolar proteinosis. Hematopoietic stem cell transplantation reverses most of the clinical phenotype with good long-term outcomes.
More Related Videos
06:51Light-sheet Fluorescence Microscopy to Capture 4-Dimensional Images of the Effects of Modulating Shear Stress on the Developing Zebrafish Heart
Published on: August 10, 2018
09:37Navigating MARRVEL, a Web-Based Tool that Integrates Human Genomics and Model Organism Genetics Information
Published on: August 15, 2019
Related Concept Videos
01:27Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
01:43Incomplete Dominance
01:20Inborn Errors of Metabolism
02:41Lethal Alleles
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
03:14Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
02:38The Ras Gene
Ras is a...